Clinical Trial Update: Bioavailability of Subcutaneous Dexmedetomidine [Phase 4]

View source ↗

Summary

Phase 4 trial report on the bioavailability of subcutaneous dexmedetomidine for pain management completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Turku University Hospital | Conditions: Pain | Phase 4 | Status: COMPLETED